Skandinaviska Enskilda Banken (SEB)
ARNA

Skandinaviska Enskilda Banken (SEB)’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-9,500
Closed -$883K – 1077
2021
Q4 		$883K Sell
9,500
-3,802
-29% -$250K ﹤0.01% 787
2021
Q3 		$792K Hold
13,302
– – ﹤0.01% 821
2021
Q2 		$907K Buy
+13,302
New +$867K 0.01% 824
2020
Q2 		– Sell
-40,200
Closed -$1.69M – 1101
2020
Q1 		$1.69M Sell
40,200
-9,900
-20% -$454K 0.02% 514
2019
Q4 		$2.28M Buy
50,100
+5,000
+11% +$236K 0.02% 529
2019
Q3 		$2.06M Buy
45,100
+500
+1% +$28.1K 0.02% 531
2019
Q2 		$2.62M Buy
+44,600
New +$2.31M 0.02% 440

Skandinaviska Enskilda Banken (SEB)'s ARNA Position: Q1 2022 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 9,500 shares — an estimated $883K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in ARNA in Q2 2019 and held it in 7 quarters. The position peaked at $2.62M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 9,500 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $883K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Arena Pharmaceuticals Inc in Q2 2019 and held it in 7 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Arena Pharmaceuticals Inc position peaked at $2.62M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2022, filed 11 May 2022.